Slovenia
Industry
Slovenian pharmaceutical company Lek, a division of Novartis's generic arm Sandoz, has opened a new US$3.8mn biopharmaceutical production facility to produce biosimilar epoetin alfa....
2010-03-12Industry
The Slovenian government approved a draft Health Services Act in March 2010, laying the groundwork for system reform in the country. The act introduces a number of reforms that will...
2010-03-09Companies
Slovenian generic drugmaker Krka plans to continue its strong organic growth strategy during 2010, while also eyeing potential takeover opportunities. Chief Executive Jože Colarič...
2010-02-04Industry
BMI forecasts that pharmaceutical sales in Emerging Europe will grow by 125% over the next decade, representing a compound annual growth rate (CAGR) of 8.43%. With global sales projected...
2010-01-05Industry
Slovenia-based generic drugmaker Krka has been criticised by Lithuania's Ethical Pharmaceutical Companies Association (EFA) for failing to comply with the country's 'Code of Pharmaceutical...
2010-01-04Industry
BMI's regional outlook for pharmaceutical companies in Emerging Europe has improved marginally, following an update to our Pharmaceuticals & Healthcare Business Environment Ratings....
2009-10-30Industry
Half-yearly results from Slovenian pharmaceutical firm Krka have highlighted strong performance in the company's Western Europe and Overseas (which includes any markets outside of...
2008-08-26Industry
The first half of 2008 has brought mixed results for pharmaceutical companies operating in Romania. Often considered as a high potential market for investment, it appears that the...
2008-07-31
